Analysis of HMG protein binding to DNA modified with the anticancer drug cisplatin

Cancer Chemotherapy and Pharmacology

Volumn 38, Issue 2, 1996, Pages 163-168

  Cryer, Jonathan E ^a   Johnson, Steven W ^b   Engelsberg, Beatrice N ^a   Billings, Paul C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

CDDP DNA; cisplatin; HMG proteins

Indexed keywords

CISPLATIN; ENDOGENOUS COMPOUND; HIGH MOBILITY GROUP PROTEIN;

ARTICLE; CHROMATIN; CONTROLLED STUDY; DRUG DNA BINDING; DRUG PROTEIN BINDING; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CATTLE; CISPLATIN; DNA ADDUCTS; DNA-BINDING PROTEINS; HIGH MOBILITY GROUP PROTEINS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES;

EID: 0030000709     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050465     Document Type: Article

References (29)

1. Alberts DS, Garcia D, Mason-Liddil N (1991) Cisplatin in advanced cancer of the cervix: an update. Semin Oncol 18: 11-24
2. Andrews PA, Howell SB (1990) Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 2: 35-43
3. +. Biophys Chem 35: 179-188
4. Bianchi ME, Falciola L, Ferrari S, Lilley DMJ (1992) The DNA binding site of HMG1 is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins. EMBOJ 11: 1055-1063
5. Billings PC, Davis RJ, Engelsberg BN, Skov KA, Hughes EN (1992) Characterization of High mobility group protein binding to cisplatin-damaged DNA. Biochem Biophys Res Comm 188: 1286-1294
6. Billings PC, Engelsberg BN, Hughes EN (1992) Proteins binding to cisplatin damaged DNA in human cell lines. Cancer Invest 12: 597-604
7. Bustin M, Lehn DA, Landsman D (1990) Structural features of the HMG chromosomal proteins and their genes. Biochem Biophys Acta 1049: 231-243
8. Chow CS, Whitehead, JP Lippard SJ (1994) HMG domain proteins induce sharp bends in cisplatin-modified DNA. Biochemistry 33: 15124-15130
9. Chu G (1994) Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. J Biol Chem 269: 787-790
10. Clark JR, Dreyfuss, AI (1991) The role of cisplatin in treatment regimens for squamous cell carcinoma of the head and neck. Semin. Oncol. 18: 34-48
11. Deng WP, Nickoloff JA (1992) Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal. Biochem 200: 81-88
12. Einhorn LH (1991) Treatment of testicular cancer: a new and improved model. J. Clin. Oncol. 8: 1777-1781
13. Falciola L, Murchie AIM, Lilley DMJ, Bianchi ME (1994) Mutational analysis of the DNA binding domain A of chromosomal protein HMG1. Nucl Acids Res 22: 285-292
14. Godwin AK, Meister, A, O'Dwyer PJ, Huang CS, Hamilton TC, Anderson ME (1992) High resistance to cisplatin in human ovarian cancer is associated with marked increase in glutathione synthesis. Proc Natl Acad Sci USA 89: 3070-3074
15. Grosschedl R, Giese K, Pagel J (1994) HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet 10: 94-100
16. Huang JC, Zamble DB, Reardon JT, Lippard SJ. Sancar A (1994) HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease. Proc Natl Acad Sci USA 91: 10394-10398
17. Hughes EN, Engelsberg BN, Billings PC (1992) Purification of nuclear proteins that bind to cisplatin-damaged DNA: identity with high mobility group proteins 1 and 2. J Biol Chem 267: 13520-13527
18. Jantzen HM, Admon A, Bell SP, Tjian R (1990) Nucleolar transcription factor hUBF contains a DNA-binding motif with homology to HMG proteins. Nature 344: 830-836
19. Laemmli UK (1970) Cleavage of structural proteins during the assembly of bacteriophage T4. Nature 227: 680-685
20. Landsman D, Bustin M (1993) A signature for the HMG-1 box DNA-binding proteins. Bioessays 15: 539-546
21. Lawrence DL, Engelsberg BN, Farid RS, Hughes EN, Billings PC (1993) Localization of the binding region of high mobility group protein 2 to cisplatin-Damaged DNA. J Biol Chem 268: 23940-23945
22. Leichman L, Berry BT (1991) Experience with cisplatin in treatment regimens for esophageal cancer. Semin Oncol 18: 64-72
23. Ozols RF (1990) New approaches to management of ovarian cancer. Adv Oncol 6: 9-17
24. Ozols RF, Young RC (1991) Chemotherapy of ovarian cancer. Semin Oncol 18: 222-232
25. Pil PM, Lippard SJ (1992) Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin. Science 256: 234-237
26. Raghavan D, Pearson B, Watt WH, Mameghan H, Langdon P, Eisinger D, Wines R (1991) Cytotoxic chemotherapy for advanced bladder cancer: cisplatin containing regimens. Semin Oncol 18: 56-63
27. Sinclair AH, Berta P, Palmer MS, Hawkins JR, Griffiths BL, Smith MJ, Foster JW, Frischauf AM, Lovell BR, Goodfellow PN (1990) A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346: 240-244
28. Timmer-Bosscha M, Mulder NH, Vries EGE de (1992) Modulation of cis-diamminedichloroplatinum (II) resistance: a review. Br J Cancer 66: 227-238
29. Turrisi III AT (1991) The integration of platinum and radiotherapy in the treatment of lung cancer. Semin Oncol 18: 81-87